Five More Years for WHO Chief is Untenable, Says AHF
- Wall Street flat, IBM results weigh on technology stocks
- Tesla (TSLA) Beats EPS and Revenue Views on Improving Gross Margins, Analysts Praise Very Solid Quarter But Warn of 'Aggressive Valuation' as Stock 'Priced to Perfection'
- Trump Media To Go Public Via $1.7 Billion SPAC Deal, Aims to Fight the Big Tech
- IBM (IBM) Stock Plunges 5% on Sales Miss, Q3 Results Seen as a Setback
- Oil hits multi-year high above $86, then pulls back
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
LOS ANGELES--(BUSINESS WIRE)-- In response to a Reuters story which says World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus is running unopposed for a second term at the agency’s helm, AIDS Healthcare Foundation (AHF) has labeled the process an utter travesty and urged United Nations Member States not to extend WHO Chief’s disastrous tenure for another five years.
According to unnamed sources quoted by Reuters, no other candidates are in contention for the top post at the WHO, even though Tedros’ own government in Ethiopia does not support his nomination and his performance has been repeatedly criticized. Any UN Member State can nominate candidates, but the deadline is set to run out this week. The final decision on who will lead the WHO will be made at the World Health Assembly in May 2022.
“Looking back at the past five years, can we say with full confidence that this is a leader fit for shepherding the world through the largest public health disaster of our time? Or are we stuck in a seemingly perpetual game of catch-up with the pandemic because the WHO Chief failed to prioritize public health from the outset despite many alarm bells and reams of unheeded recommendations?” said AHF President Michael Weinstein. “We will have more of the same, if the WHO leadership remains in place -- two years into the pandemic the world cannot afford that. This must not be an ‘election’ like those held in North Korea, where the outcome is known well before any votes are cast. We need a large and diverse pool of candidates to find the best possible person to lead the WHO. Surely, among 194 Member States there must be candidates worthy of consideration. Business as usual is simply inexcusable at this point.”
In June, AHF outlined six reasons why the WHO Chief should not be re-elected, they include the following:
1. WHO delayed declaring COVID-19 a pandemic.
2. Lack of transparency regarding the origin of COVID-19.
3. Inability to mobilize and coordinate resources to help low- and middle-income countries.
4. Delays in vaccine approvals.
5. Lack of authoritative guidance in preventing and responding to public health crises.
6. Failure to implement previous proposals to radically reform WHO.
The full statement titled “Six Reasons Why WHO Chief Should Go” is available here.
AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.6 million clients in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.
US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1.323.308.1833 work +1.323.791.5526 mobile
Denys Nazarov, Director of Global Policy & Communications, AHF
Source: AIDS Healthcare Foundation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MediStreams Partners with TT Capital Partners to Accelerate Growth
- CMP Pumping Announces New Safety Director, Kevin Smith
- CCI Systems Wins 2021 Calix Partner of the Year Award, Showing Breakout Business Performance and Boosting Success for Multiservice Operators
Create E-mail Alert Related CategoriesBusiness Wire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!